Modified bill on drug patent rights advances in Israel

09/15/2004 | Globes (Israel)

Israel's economic-social cabinet approved a modified version of a pharmaceutical intellectual property protection bill that may ease some objections by foreign drugmakers, though the U.S. is expected to object to the terms of the amended bill. The cabinet postponed action on a provision that would have enabled Israeli firms to begin developing generic drugs before foreign firms' patents expired in the country. The bill is to be attached to the 2005 budget law.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD